Á lódáil...
Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
Human epidermal growth factor receptor 2 (HER2) plays an important role in the pathogenesis of various cancers. HER2 alterations have been suggested to be a therapeutic target in non‐small‐cell lung cancer (NSCLC), just as in breast and gastric cancers. We previously reported that the pan‐HER inhibi...
Na minha lista:
| Foilsithe in: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley and Sons Inc.
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980184/ https://ncbi.nlm.nih.gov/pubmed/29532558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13571 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|